Galectin Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Galectin Therapeutics Inc's ROI in the second quarter of 2026?
Galectin Therapeutics Inc recorded a cumulative net loss of $-28 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -1.17%.

Within the Healthcare sector 198 other companies had a higher return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	9,589	8	12	-124	5
Return On Investment (TTM)	-1.17 %	106.35 %	59.06 %	-	145.59 %
GALT's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-28	-26	-31	-37	-40

GALT Company Profile >> Back to GALT Roi Comparisons >> See Annual GALT Return On Investment

Return On Investment GALT's Ranking
Within:	No.
Industry	# 68
Sector	# 199
Overall	#

Return On Investment Statistics
High	Average	Low
-1.17 %	-257.59 %	-1579.59 %
(Jun 30 2026)		(Sep 30 2013)

Financial Statements
Galectin Therapeutics Inc's II. Quarter Investments	$ 9,589 Millions	GALT's Balance sheet
Galectin Therapeutics Inc's II. Quarter Income	$ -9 Millions	Quarterly GALT's Income Statement
GALT's Income by Division		See GALT's Income by Division

GALT Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	-122	-18	13	8	33
Y / Y Investment Growth	-	-	51.38 %	-74.77 %	35.51 %
Net Income in Millions	-31	-47	-45	-39	-31
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-356.79 %	-468.71 %	-93.09 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GALT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GALT's Competitors
Subscribers only: Roi for Galectin Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for GALT's Customers

Other Ratios
GALT's Roa	GALT's Inventory Turnover Ratio	GALT's Growth Rates	GALT's Dividend Statistics
	GALT's Profitability Ratios	GALT's Asset Turnover Ratio	GALT's Dividend Growth
GALT's Roe	GALT's Valuation Ratios	GALT's Financial Strength Ratios	GALT's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:08:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.